[1]Heterocycles,2018,vol.96,#1,p.74-85
[1]JournaloftheAmericanChemicalSociety,1998,vol.120,#33,p.8340-8347
[2]Patent:WO2005/37763,2005,A1,.Locationinpatent:Page/Pagecolumn126
[3]Patent:US2017/37038,2017,A1,.Locationinpatent:Paragraph0372;0373;0374
[4]JournaloftheAmericanChemicalSociety,1946,vol.68,p.2502
[5]EuropeanJournalofMedicinalChemistry,1996,vol.31,#6,p.449-460
[1]OrganicSyntheses,2005,vol.82,p.64-68
[2]OrganicandBiomolecularChemistry,2017,vol.15,#6,p.1530-1536
[3]JournaloftheChemicalSociety,PerkinTransactions1:OrganicandBio-OrganicChemistry(1972-1999),1994,#13,p.1823-1832
[4]TetrahedronLetters,2005,vol.46,#19,p.3357-3358
[5]TetrahedronLetters,2005,vol.46,#32,p.5285-5287
[6]JournalofMedicinalChemistry,2000,vol.43,#24,p.4701-4710
[7]BioorganicandMedicinalChemistryLetters,2008,vol.18,#20,p.5591-5593
[8]BioorganicandMedicinalChemistryLetters,2010,vol.20,#6,p.1939-1943
[9]Chemistry-AEuropeanJournal,2017,vol.23,#68,p.17195-17198
[10]OrganicLetters,2017,vol.19,#23,p.6340-6343
[1]Patent:WO2016/201168,2016,A1,.Locationinpatent:Paragraph0512;0513
[1]SyntheticCommunications,2000,vol.30,#3,p.397-405
[1]SyntheticCommunications,2000,vol.30,p.397-405
[1]Blair;Kurrasch-Orbaugh;Marona-Lewicka;Gumbay;Watts;Barker;Nichols[JournalofMedicinalChemistry,2000,vol.43,#24,p.4701-4710]
[1]Chemistry-AEuropeanJournal,2002,vol.8,p.5033-5042
[1]Song,Xiao-Guang;Zhu,Shou-Fei;Xie,Xiu-Lan;Zhou,Qi-Lin[AngewandteChemie-InternationalEdition,2013,vol.52,#9,p.2555-2558][Angew.Chem.,2013,vol.125,#9,p.2615-2618,4]
[2]CurrentPatentAssignee:ARVINAS;YALEUNIVERSITY-WO2018/119441,2018,A1Locationinpatent:Paragraph001010;101011
[3]CurrentPatentAssignee:GILEADSCIENCESINC-US2017/166584,2017,A1Locationinpatent:Paragraph0567-0569
[4]Chen,Han;Fan,Yun-Hua;Natarajan,Amarnath;Guo,Yuhong;Iyasere,Julia;Harbinski,Fred;Luus,Lia;Christ,William;Aktas,Huseyin;Halperin,JoseA.[BioorganicandMedicinalChemistryLetters,2004,vol.14,#21,p.5401-5405]
[5]Wang,Xiaoming;Wang,Xubin;Guo,Peihua;Wang,Zheng;Ding,Kuiling[AdvancedSynthesisandCatalysis,2013,vol.355,#14-15,p.2900-2907]
[6]CurrentPatentAssignee:ABBVIEINC-WO2017/89458,2017,A1Locationinpatent:Page/Pagecolumn78
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2017/4342,2017,A1Locationinpatent:Paragraph0500
[2]CurrentPatentAssignee:SHENZHENTARGETRXINC-EP3770161,2021,A1Locationinpatent:Paragraph0116;0117
[3]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2017/7759,2017,A1Locationinpatent:Paragraph0245;0252;0253
[4]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2017/15367,2017,A1Locationinpatent:Paragraph0412;0419;0420
[5]CurrentPatentAssignee:GUANGZHOUBAITINGMEDICINETECH-CN114763360,2022,ALocationinpatent:Paragraph0092-0096;0113-0117;0132-0136;0140-0144;...
[6]Pei,Dong;Wang,Zhouyu;Wei,Siyu;Zhang,Yu;Sun,Jian[OrganicLetters,2006,vol.8,#25,p.5913-5915]
[7]Zhao,Yun-Hui;Ren,Xin-Fang;Liu,Han-Wen[SyntheticCommunications,2015,vol.45,#13,p.1566-1573]
[8]Xiao,Xiaofei;Xu,Yunsheng;Yu,Xihua;Chen,Yinbo;Zhao,Weiwei;Xie,Zhendong;Zhu,Xueyan;Xu,Hongjiang;Yang,Yulei;Zhang,Peng[BioorganicandMedicinalChemistryLetters,2023,vol.89]
[9]Xiao,Xiaofei;Xu,Yunsheng;Yu,Xihua;Chen,Yinbo;Zhao,Weiwei;Xie,Zhendong;Zhu,Xueyan;Xu,Hongjiang;Yang,Yulei;Zhang,Peng[BioorganicandMedicinalChemistryLetters,2023,vol.89]
Title: 4-Fluoro-2-[(3-methyl-phen-yl)imino-meth-yl]phenol.
Journal: Acta crystallographica. Section E, Structure reports online 20120401
Title: (E)-4-Fluoro-2-[(4-hy-droxy-pheneth-yl)imino-meth-yl]phenol.
Journal: Acta crystallographica. Section E, Structure reports online 20120201
Title: 2-Fluoro-6-[(E)-(pyridin-2-yl)imino-meth-yl]phenol.
Journal: Acta crystallographica. Section E, Structure reports online 20111201
Title: Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
Journal: European journal of medicinal chemistry 20100901
Title: 4-Fluoro-2-[(E)-2-pyridyliminomethyl]phenol.
Journal: Acta crystallographica. Section E, Structure reports online 20090601